People | July 11, 2022
Piramal Pharma strengthens board by inducting three new board members
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states
Scemblix (asciminib) continues to show superior efficacy with more-than-two-fold improvement in major molecular response rate vs. Bosulif (bosutinib) at 96 weeks
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
Objective tracking data combined with cohort data to drive medicine of the future
Subscribe To Our Newsletter & Stay Updated
